• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

机器学习在脂质体制剂与研发中的应用

'Applications of machine learning in liposomal formulation and development'.

作者信息

Matalqah Sina, Lafi Zainab, Mhaidat Qasim, Asha Nisreen, Yousef Asha Sara

机构信息

Pharmacological and Diagnostic Research Center, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan.

King Hussein Cancer Center-Amman, Jordan.

出版信息

Pharm Dev Technol. 2025 Jan;30(1):126-136. doi: 10.1080/10837450.2024.2448777. Epub 2025 Jan 11.

DOI:10.1080/10837450.2024.2448777
PMID:39780760
Abstract

Machine learning (ML) has emerged as a transformative tool in drug delivery, particularly in the design and optimization of liposomal formulations. This review focuses on the intersection of ML and liposomal technology, highlighting how advanced algorithms are accelerating formulation processes, predicting key parameters, and enabling personalized therapies. ML-driven approaches are restructuring formulation development by optimizing liposome size, stability, and encapsulation efficiency while refining drug release profiles. Additionally, the integration of ML enhances therapeutic outcomes by enabling precision-targeted delivery and minimizing side effects. This review presents current breakthroughs, challenges, and future opportunities in applying ML to liposomal systems, aiming to improve therapeutic efficacy and patient outcomes in various disease treatments.

摘要

机器学习(ML)已成为药物递送领域的一种变革性工具,尤其是在脂质体制剂的设计和优化方面。本综述聚焦于机器学习与脂质体技术的交叉领域,强调先进算法如何加速制剂工艺、预测关键参数并实现个性化治疗。机器学习驱动的方法正在通过优化脂质体大小、稳定性和包封效率,同时改善药物释放曲线,对制剂开发进行重塑。此外,机器学习的整合通过实现精准靶向递送和最小化副作用,提高了治疗效果。本综述介绍了将机器学习应用于脂质体系统的当前突破、挑战和未来机遇,旨在提高各种疾病治疗中的治疗效果和患者预后。

相似文献

1
'Applications of machine learning in liposomal formulation and development'.机器学习在脂质体制剂与研发中的应用
Pharm Dev Technol. 2025 Jan;30(1):126-136. doi: 10.1080/10837450.2024.2448777. Epub 2025 Jan 11.
2
Computational Design and Optimization of Multi-Compound Multivesicular Liposomes for Co-Delivery of Traditional Chinese Medicine Compounds.用于中药化合物共递送的多复合多囊脂质体的计算设计与优化
AAPS PharmSciTech. 2025 Feb 11;26(2):61. doi: 10.1208/s12249-025-03042-6.
3
Advancements in liposomal formulations: A comprehensive exploration of industrial production techniques.脂质体制剂的进展:工业生产技术的全面探索
Int J Pharm. 2024 Jun 10;658:124212. doi: 10.1016/j.ijpharm.2024.124212. Epub 2024 May 8.
4
Development and optimization of an in vitro release assay for evaluation of liposomal irinotecan formulation.开发和优化体外释放测定法评价脂质体伊立替康制剂。
Int J Pharm. 2024 Dec 25;667(Pt A):124854. doi: 10.1016/j.ijpharm.2024.124854. Epub 2024 Oct 21.
5
Preparation, characterization, in vitro and in vivo studies of liposomal berberine using novel natural Fiber Interlaced Liposomal technology.采用新型天然纤维交织脂质体技术制备、表征并研究脂质体小檗碱的体外和体内研究。
Eur J Pharm Biopharm. 2024 Oct;203:114431. doi: 10.1016/j.ejpb.2024.114431. Epub 2024 Jul 31.
6
Machine learning directed drug formulation development.机器学习指导药物制剂开发。
Adv Drug Deliv Rev. 2021 Aug;175:113806. doi: 10.1016/j.addr.2021.05.016. Epub 2021 May 19.
7
Advancements in Liposomal Nanomedicines: Innovative Formulations, Therapeutic Applications, and Future Directions in Precision Medicine.脂质体纳米药物的进展:创新制剂、治疗应用及精准医学的未来方向
Int J Nanomedicine. 2025 Jan 31;20:1213-1262. doi: 10.2147/IJN.S488961. eCollection 2025.
8
Machine Learning-Driven Advancements in Liposomal Formulations for Targeted Drug Delivery: A Narrative Literature Review.机器学习驱动的靶向给药脂质体制剂进展:叙述性文献综述
Curr Drug Deliv. 2024 Jun 27. doi: 10.2174/0115672018302321240620072039.
9
Liposomal adjuvants: preparation and formulation with antigens.脂质体佐剂:与抗原的制备和配方
Methods Mol Biol. 2010;626:73-90. doi: 10.1007/978-1-60761-585-9_6.
10
Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environments.冻干脂质体注射剂药物研发:复杂产品设计策略与现行监管环境综述。
Adv Drug Deliv Rev. 2019 Nov-Dec;151-152:56-71. doi: 10.1016/j.addr.2019.03.003. Epub 2019 Mar 18.

引用本文的文献

1
Phospholipid-Drug Conjugates in Cancer Therapy: Emerging Paradigms and Future Directions.癌症治疗中的磷脂-药物偶联物:新兴模式与未来方向
AAPS PharmSciTech. 2025 Jul 14;26(6):190. doi: 10.1208/s12249-025-03175-8.
2
Next-generation cancer therapeutics: unveiling the potential of liposome-based nanoparticles through bioinformatics.下一代癌症治疗方法:通过生物信息学揭示基于脂质体的纳米颗粒的潜力。
Mikrochim Acta. 2025 Jun 16;192(7):428. doi: 10.1007/s00604-025-07286-8.